Hopp til innhold
NHI.no
Annonse

Denguefeber: Prognose

Innhold i artikkelen

Prognosen er god hos tidligere friske personer. Denguefeber er vanligvis selvbegrensende og har en dødelighet under 1 prosent. Sykdom medfører livsvarig immunitet for den aktuelle serotype (type 1-4), men ingen kryssimmunitet. 

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Denguefeber . Referanselisten for dette dokumentet vises nedenfor

  1. World Health Organization, Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever - revised and expanded edition. 2011. http://www.searo.who.int/ (last accessed 29 June 2015).
  2. Centers for Disease Control and Prevention. Dengue. For health care providers. July 14, 2020. www.cdc.gov
  3. Smittevernveilederen. Denguefeber - veileder for helsepersonell. Folkehelseinstituttet, siste oppdatering 08.08.2019. fhi.no
  4. Fokehelseinstituttet. Denguefeber - håndbok for helsepersonell. Sist oppdatert 11.07.2024. Siden lest 05.09.2024. www.fhi.no
  5. Vita S, Bordi L, Sberna G, et al. Autochthonous dengue fever in 2 patients, Rome, Italy. Emerg Infect Dis 2024; 30: 183-184. PMID: 37967518 PubMed
  6. WHO. Dengue and severe dengue. 23 June 2020. www.who.int
  7. Simmons CP, Farrar JJ, Nguyen VV, et al. Dengue. N Engl J Med. 2012;366:1423-1432. PubMed
  8. Blystad H, Borgen K. Dødelig denguevirus-infeksjon etter turistopphold i Thailand. MSIS 2008; 36: 9. PubMed
  9. Guzman MG, Kouri G. Dengue and dengue haemorrhagic fever in America: lessons and challenges. J Clin Virol. 2007;27:1-13. PubMed
  10. Gregory CJ, Santiago LM, Argüello LM, et al. Clinical and laboratory features that differentiate dengue from other febrile illnesses en an endemic area--Puerto Rico, 2007-2008. Am J Trop Med Hyg 2010; 82: 922-9. PubMed
  11. Lindegren G, Vene S, Lundkvist Å, Falk KI. Optimized diagnosis of acute dengue fever in Swedish travelers by a combination of reverse transcription-PCR and immunoglobin M detection. J Clin Microbiol 2005; 43: 2850-5. PubMed
  12. World Mosquito Program. Wolbachia. Siden besøkt 10.01.2020. www.eliminatedengue.com
  13. Utarini A, Indriani C, Ahmad RA, et al. Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue. N Engl J Med 2021; 384: 2177-86. pmid:34107180 PubMed
  14. Folkehelseinstituttet. Denguefeber - Vaksinasjonsveilederen for helsepersonell. Publisert 24.03.2023. Siden lest 19.10.2023 www.fhi.no
  15. EMA, Qdenga: EPAR - Product information. 2022 www.ema.europa.eu
  16. Nilsson J, Vene S, Mattsson L. Dengue encephalitis in a Swedish traveller returning from Thailand. Scand J Infect Dis 2005; 776-8.
  17. Blacksell SD, Newton PN, Bell D, Kelley J, Mammen MP, Vaughn DW et al. The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection. Clin Infect Dis 2006; 42: 1127-34. PubMed
  18. European Centre for Disease Prevention and Control. Dengue worldwide overview. 20.December 2019. www.ecdc.europa.eu
  19. Thomas SJ, Rothman AL, Srikiatkhachorn A, Kalayanarooj S. Dengue virus infection: Prevention and treatment. UpToDate, last updated Sep 11, 2018. UpToDate
Annonse
Annonse